Filtering by:
Non-Hodgkin LymphomaFDA Approves Poteligeo (Mogamulizumab) for Lymphoma of the Skin
The US Food and Drug Administration (FDA) has approved Poteligeo (mogamulizumab) to treat people with some types of skin lymphoma.
FDA Approves Calquence (Acalabrutinib) for Mantle Cell Lymphoma
The US Food and Drug Administration (FDA) has approved a targeted therapy for treating certain adults with mantle cell lymphoma.
FDA Approves Yescarta (Axicabtagene Ciloleucel) for Adults with Certain Lymphomas
The US Food and Drug Administration (FDA) has approved Yescarta (axicabtagene ciloleucel) to treat adults with certain types of large B-Cell lymphoma.
Brain Tumor Survivor Puts a Positive Spin on Treatment
Howard Tolchin figured if he had to spend every other week in the hospital getting chemotherapy for a brain tumor, he was going to make the most of it.
FDA Approves Imbruvica (Ibrutinib) for Waldenstrom Macroglobulinemia
The US Food and Drug Administration has approved Imbruvica (Ibrutinib) for people with Waldenstrom Macroglobulinemia.
FDA Approves Idelalisib (Zydelig) for Leukemia and Lymphoma
The U.S. Food and Drug Administration (FDA) has approved idelalisib (Zydelig) for people with relapsed chronic lymphocytic leukemia (CLL), relapsed follicular B-cell non-Hodgkin lymphoma, and relapsed small lymphocytic lymphoma (another type of non-Hodgkin lymphoma).
FDA Approves Beleodaq (belinostat) for Type of T-cell Lymphoma
The US Food and Drug Administration (FDA) has approved Beleodaq (belinostat) for people with peripheral T-cell lymphoma who did not get better after treatment with other drugs, or whose cancer came back after treatment with other drugs.
Lymphoma Survivor: ‘The World is so Kind’
Going public with her lymphoma battle was not easy for Nina Polvanich Louie, 33. “As a cancer patient, I didn’t feel comfortable sharing my private, painful moments,” she said.